A randomized clinical trial of combination chemotherapy with and without low‐molecular‐weight heparin in small cell lung cancer
Top Cited Papers
- 1 August 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 2 (8), 1266-1271
- https://doi.org/10.1111/j.1538-7836.2004.00871.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Chemotherapy for small cell lung cancerSeminars in Oncology, 2003
- Anticoagulants in cancer treatment: malignancy as a solid phase coagulopathyCancer Letters, 2002
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- Heparin reverses Rhodamine 123 extrusion by multidrug resistant cellsCancer Letters, 1996
- Alteration of coagulation and fibrinolysis systems after multidrug anticancer therapy for lung cancerEuropean Journal Of Cancer, 1994
- No effect of an antiaggregant treatment with aspirin in small cell lung cancer treated with CCAVP16 chemotherapy results from a randomized clinical trial of 303 patientsCancer, 1993
- Thromboembolism in cancer. Changing trendsCancer, 1993
- Urokinase combination chemotherapy in small cell lung cancer. A phase II studyCancer, 1992
- Abnormal regulation of coagulation/fibrinolysis in small cell carcinoma of the lungCancer, 1990
- A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.Journal of Clinical Oncology, 1989